Stimcell Energetics (STME) Cash from Financing Activities (2011 - 2026)
Stimcell Energetics (STME) posted quarterly Cash from Financing Activities of $50000.0 for Q1 2026, up 198.6% year-over-year from $16745.0 in Q1 2025, and down 56.24% quarter-over-quarter from $114248.0 in Q4 2025.
Stimcell Energetics (STME) Cash from Financing Activities (2011 - 2026) Analysis & Trends
Stimcell Energetics' Cash from Financing Activities history runs 13 years deep, the most recent figure standing at $50000.0 for Q1 2026.
- In Q1 2026, Cash from Financing Activities rose 198.6% year-over-year to $50000.0; the TTM figure through Feb 2026 stood at $330361.0 (up 672.27% YoY), while the FY2025 annual figure was $112858.0, up 23.97% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at $50000.0, down from $114248.0 in the prior quarter.
- The five-year high for Cash from Financing Activities was $116377.0 in Q2 2023, with the low at -$3967.0 in Q2 2024.
- The 5-year median for Cash from Financing Activities is $78686.0 (2022), against an average of $70257.1.
- The sharpest annual moves came in 2024 and 2025: Cash from Financing Activities slumped 103.41% in 2024, then surged 1766.57% in 2025.
- Stimcell Energetics' Cash from Financing Activities stood at $76372.0 in 2022, then soared by 52.38% to $116377.0 in 2023, then plunged by 74.22% to $30000.0 in 2024, then jumped by 280.83% to $114248.0 in 2025, then sank by 56.24% to $50000.0 in 2026.
- Business Quant data shows STME's Cash from Financing Activities at $50000.0 in Q1 2026, $114248.0 in Q4 2025, and $100000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Stimcell Energetics | 4.65 Mn | 4.64 Mn | - | 50,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 50,000.00 |
| Feb 28, 2026 | 50,000.00 |
| Nov 30, 2025 | 114,248.00 |
| Nov 30, 2025 | 114,248.00 |
| Aug 31, 2025 | 100,000.00 |
| Aug 31, 2025 | 100,000.00 |
| May 31, 2025 | 66,113.00 |
| May 31, 2025 | 66,113.00 |
| Feb 28, 2025 | 16,745.00 |
| Feb 28, 2025 | 16,745.00 |
| Nov 30, 2024 | 30,000.00 |
| Nov 30, 2024 | 30,000.00 |
| May 31, 2024 | -3,967.00 |
| May 31, 2024 | -3,967.00 |
| Feb 29, 2024 | 95,000.00 |
| Feb 29, 2024 | 95,000.00 |
| May 31, 2023 | 116,377.00 |
| May 31, 2023 | 116,377.00 |
| Feb 28, 2023 | 92,615.00 |
| Feb 28, 2023 | 92,615.00 |